Office of Research
2017 Pediatric Cancer Research Immunology or Immunotherapy
Fred Hutchinson Cancer Research Center may submit one application for the V Foundation 2017 Pediatric Cancer Research in Immunology or Immunotherapy
Synopsis:
This is a new grant opportunity in pediatric cancer immunology or pediatric cancer immunotherapy. Ideal proposals will further advance knowledge on the mechanisms driving anti-cancer immunity, including work on tumor antigens, immune biomarkers and the tumor immune microenvironment which may have future translational value.
- Proposals may focus on various immunotherapy/ cancer immunology research questions as applied to pediatric cancer, including: biomarker research for stratification, biomarker validation research, combination of checkpoint inhibitors with vaccines.
- Cross-disciplinary research encouraged, including expertise from other disciplines (i.e.: bioinformatics, computational scientists, or engineers) as applicable to the research.
- Grants will be awarded through the Translational Award grant mechanism.
- Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms.
- The research should apply in some direct way to human beings within the time frame of less than 5 years.
- If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal.
- The endpoint of the project should be the planning or initiation of a new clinical trial.
Funding:
- $200,000 per year for three years
- NIH salary caps are observed
- Max of 10% IDC. This award is not listed on Exhibit A. The endorsed applicants must have Division or Fred Hutch Director’s Office approval for unrecovered F&A costs before submitting an application and should work with their Division Administrator to complete this task. For further information, see the Fred Hutch Foregone F&A Cost Policy.
Eligibility:
- Applicants must be either US Citizens or have a legal permit to work in the USA (either temporary or permanent).
- PIs must hold a faculty position at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for Principal Investigator nomination to lead the Translational Research Team.
Additional Information:
- Questions from interested individuals may be directed to fundinginfo@fredhutch.org.
Application Instructions
Fred Hutch Internal Pre-Proposal Deadline. Interested investigators must submit a pre-proposal to the Office of Sponsored Research by this time to be considered by the Internal Awards Committee.
Eligible investigators must submit the following pre-proposal materials as a single PDF with the following naming convention: Candidate’s Last Name_2017_VFound_PediatricImmunolgy.pdf
- 1-2 pages of proposed research
- Current curriculum vitae or biosketch
- Letter of support from candidate’s Division Director
Please submit a single PDF containing all pre-proposal materials to: fundinginfo@fredhutch.org
Inquiries and Contact Information
Investigators who identify a grant, award or fellowship program that restricts the number of applications that can be submitted from an Institution should immediately contact their Chairperson, Associate Dean for Research (or Dean, if no ADR) and the Office of Research (see below) if they intend to prepare a response. Failure to do so, or to meet the deadlines for submission of pre-proposal, will preclude submission of the application through the Office of Sponsored Programs.
For general inquiries, or to request a listing of a limited submission opportunity that should be but is not already listed, please email us at limitedsubs@uw.edu.